큐렉소
Financials
Valuation Metrics
큐렉소's Market Cap is ₩3309B. At end of 2025 it was ₩5347B. Ranked #617 of 2,421 in KR market (top 25%), #253 of 1,640 on KOSDAQ (top 15%), #6 of 10 in Consumer Staples Distribution & Retail (top 60%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 330.90B KRW | KR#617/2,421 Sec#6/10 |
| Revenue | 77.74B KRW | KR#1,559/2,421 Sec#10/10 |
| Net Income | 5.51B KRW | KR#1,167/2,421 Sec#8/10 |
| Total Assets | 111.45B KRW | KR#1,689/2,421 Sec#9/10 |
| Net Assets | 100.88B KRW | KR#1,407/2,421 Sec#8/10 |
| Employees | 99 | KR#1,644/2,421 Sec#7/10 |
| Value | ||
| P/E | 60.04x | KR#1,440/2,421 Sec#9/10 |
| P/B | 3.28x | KR#2,133/2,421 Sec#10/10 |
| P/S | 4.26x | KR#2,099/2,421 Sec#9/10 |
| EV/EBITDA | 96.87x | KR#1,488/2,421 Sec#10/10 |
| FCF Yield | -4.15% | KR—/2,421 Sec—/10 |
| Profitability | ||
| ROE | 5.46% | KR#1,045/2,421 Sec#7/10 |
| ROA | 4.95% | KR#746/2,421 Sec#5/10 |
| Op. Margin | 4.18% | KR#1,069/2,421 Sec#5/10 |
| Revenue Growth | 20.38% | KR#544/2,421 Sec#2/10 |
| Financial Health | ||
| Debt Ratio | 10.48% | KR#156/2,421 Sec#2/10 |
| Total Debt | 414.3M KRW | KR#2,000/2,421 Sec#10/10 |
| FCF | -13.74B KRW | KR#1,801/2,421 Sec#10/10 |
| Cash | 16.71B KRW | KR#1,367/2,421 Sec#10/10 |
| Current Ratio | 10.09x | KR#97/2,421 Sec#2/10 |
| Net Debt/EBITDA | -5.02x | KR#104/2,421 Sec#1/10 |
| Performance | ||
| 1Y Return | -9.48% | KR#967/2,421 Sec#6/10 |
| 1M Return | -10.69% | KR#2,126/2,421 Sec#9/10 |
| From 52W High | -64.43% | KR#2,016/2,421 Sec#10/10 |
| 1Y MDD | -64.32% | KR#1,715/2,421 Sec#10/10 |
| Trading | ||
| Volume | 441,350 shares | KR#260/2,421 Sec#1/10 |
| Trading Value | 3.65B KRW | KR#429/2,421 Sec#4/10 |
| Foreign Own. | 5.14% | KR#839/2,421 Sec#6/10 |
| Per Share | ||
| EPS | 134 KRW | KR#1,382/2,421 Sec#9/10 |
| BPS | 2,445 KRW | KR#1,967/2,421 Sec#10/10 |
Company Info
Established in 1992 and listed on KOSDAQ in 2002, this company is a specialized medical robot enterprise, planning global business expansion with a local subsidiary in India by 2025. Its medical robot business division operates the orthopedic surgical robot CUVIS-Joint, rehabilitation treatment robot Morning Walk, artificial joint prosthesis implant business, and food ingredient trading. The company addresses the demand for rehabilitation robots driven by an aging population, expands its product range through contracts with US implant specialized enterprises, and pursues medical robot technology innovation and business diversification. Curexo, established in 1992, is headquartered in Seoul Metropolitan City, Songpa-gu.